Summary

U.S. Antiseptic And Disinfectant Market Summary

The U.S. antiseptic and disinfectant market size was valued at USD 9.41 billion in 2024 and is projected to reach USD 17.07 billion by 2030, growing at a CAGR of 10.8% from 2025 to 2030. An increase in the prevalence of diseases, such as influenza, hepatitis A, typhoid, cholera, and dengue, is one of the major factors driving the antiseptic & disinfectant market growth.

According to the Centers for Disease Control and Prevention (CDC), the 2023 - 2024 flu season led to an estimated 40 million illnesses, 470,000 hospitalizations, and 28,000 deaths in the U.S. The need for effective disinfection in both healthcare and community settings drives the U.S. antiseptic and disinfectant industry. The increasing number of surgical and inpatient medical procedures in the U.S. significantly drives demand for antiseptics and disinfectants. Each procedure requires stringent sterilization protocols and aseptic practices to minimize the risk of healthcare-associated infections. The growing prevalence of chronic diseases and an aging population are contributing to higher hospitalization rates. This sustained patient volume increases surface contamination risks, reinforcing the need for consistent and effective disinfection practices across healthcare facilities.

Regulatory organizations such as the U.S. Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) play a vital role in shaping the U.S. industry. These agencies enforce strict standards for product efficacy, safety, and labeling, particularly in healthcare environments. The EPA mandates that hospital-grade disinfectants undergo rigorous testing to prove effectiveness against a broad range of pathogens. Meanwhile, the FDA oversees the safety and formulation of antiseptics used on patients. This regulatory environment encourages manufacturers to innovate and drives healthcare providers to adopt compliant, high-quality disinfection solutions.

U.S. Antiseptic And Disinfectant Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. antiseptic and disinfectant market report based on type, product type, end use, and sales channel:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Quaternary Ammonium Compounds
• Chlorine Compounds
• Alcohols & Aldehyde Products
• Enzyme
• Others
• Product Type Outlook (Revenue, USD Million, 2018 - 2030)
• Enzymatic Cleaners
• Medical Device Disinfectants
• Surface Disinfectants
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Clinics
• Other
• Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
• B2B
• FMCG

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources and Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation and Data Visualization
1.6. Data Validation and Publishing
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Antiseptic And Disinfectant Market Variables, Trends and Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Industry Challenge
3.3. Industry Analysis Tools
3.3.1. PORTER’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and social landscape
3.3.2.3. Technological landscape
Chapter 4. U.S. Antiseptic And Disinfectant Market: Type Estimates and Trend Analysis
4.1. U.S. Antiseptic And Disinfectant Market, By Type: Key Takeaways
4.2. Type Movement Analysis and Market Share, 2024 and 2030
4.3. Market Estimates and Forecasts, By Type, 2018 - 2030 (USD Million)
4.3.1. Quaternary Ammonium Compounds
4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Chlorine Compounds
4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Alcohols & Aldehyde Products
4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Enzyme
4.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Other
4.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Antiseptic And Disinfectant Market: Product Type Estimates and Trend Analysis
5.1. U.S. Antiseptic And Disinfectant Market, By Product Type: Key Takeaways
5.2. Product Type Movement Analysis and Market Share, 2024 and 2030
5.3. Market Estimates and Forecasts, By Product Type, 2018 - 2030 (USD Million)
5.3.1. Enzymatic Cleaners
5.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Medical Device Disinfectants
5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Surface Disinfectants
5.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Antiseptic And Disinfectant Market: End Use Estimates and Trend Analysis
6.1. U.S. Antiseptic And Disinfectant Market, By End Use: Key Takeaways
6.2. End Use Movement Analysis and Market Share, 2024 and 2030
6.3. Market Estimates and Forecasts, By End Use, 2018 - 2030 (USD Million)
6.3.1. Hospitals
6.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. Clinics
6.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Other
6.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Antiseptic And Disinfectant Market: Sales Channel Estimates and Trend Analysis
7.1. U.S. Antiseptic And Disinfectant Market, By Sales Channel: Key Takeaways
7.2. Sales Channel Movement Analysis and Market Share, 2024 and 2030
7.3. Market Estimates and Forecasts, By Sales Channel, 2018 - 2030 (USD Million)
7.3.1. B2B
7.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. FMCG
7.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Company Market Positioning
8.3. Company Heat Map Analysis
8.4. Company Profiles/Listing
8.4.1. 3M
8.4.1.1. Company Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Portfolio
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Reckitt Benckiser
8.4.2.1. Company Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Portfolio
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Steris Plc
8.4.3.1. Company Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Portfolio
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Kimberly-Clark Corporation
8.4.4.1. Company Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Portfolio
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Bio-Cide International, Inc.
8.4.5.1. Company Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Portfolio
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Cardinal Health
8.4.6.1. Company Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Portfolio
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. BD
8.4.7.1. Company Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Portfolio
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Johnson & Johnson
8.4.8.1. Company Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Portfolio
8.4.8.4. Recent Developments/ Strategic Initiatives